Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04376593 · ClinicalTrials.gov registry record · Early Phase 1
PET/CT Imaging in COVID-19 Patients
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT04376593 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 5 participants.
The verdict
NCT04376593, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.
Interventions
- DRUG 18F-αvβ6-BP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2026-02-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04376593
The ClinicalTrials.gov registry entry for NCT04376593 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-αvβ6-BP is the first listed.
NCT04376593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04376593 about?
NCT04376593 is a clinical study titled "PET/CT Imaging in COVID-19 Patients". This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.
What is the current status of trial NCT04376593?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2020-05-01. Estimated completion is 2026-02-23.
What interventions are being tested in trial NCT04376593?
The interventions under investigation include: 18F-αvβ6-BP (DRUG).
Who is sponsoring clinical trial NCT04376593?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.